Genor Biopharma Holdings Limited (6998.HK)
HKD 1.66
(-5.68%)
HKD 1.66
(-5.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - CNY | -100.0% |
| 2022 | 15.93 Million CNY | 0.0% |
| 2021 | - CNY | -100.0% |
| 2020 | 10.33 Million CNY | -20.77% |
| 2019 | 13.03 Million CNY | 89.47% |
| 2018 | 6.88 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.23 Million CNY | 0.0% |
| 2024 Q1 | 7.23 Million CNY | 0.0% |
| 2023 Q2 | - CNY | 0.0% |
| 2023 Q4 | - CNY | 0.0% |
| 2023 Q3 | - CNY | 0.0% |
| 2023 FY | - CNY | -100.0% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q3 | 6.48 Million CNY | 338.97% |
| 2022 Q2 | 1.47 Million CNY | 0.0% |
| 2022 Q1 | 1.47 Million CNY | 0.0% |
| 2022 FY | 15.93 Million CNY | 0.0% |
| 2022 Q4 | 6.48 Million CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | - CNY | -100.0% |
| 2021 Q4 | - CNY | 0.0% |
| 2021 Q3 | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 3.28 Million CNY | 0.0% |
| 2020 Q3 | 3.28 Million CNY | -12.51% |
| 2020 Q2 | 3.75 Million CNY | 0.0% |
| 2020 FY | 10.33 Million CNY | -20.77% |
| 2019 FY | 13.03 Million CNY | 89.47% |
| 2019 Q1 | 1.31 Million CNY | 0.0% |
| 2018 FY | 6.88 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 484.71 Million HKD | 100.0% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 100.0% |